• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在体内通过 NG-硝基-L-精氨酸甲酯(L-NAME)减少人类受试者抗原诱导的鼻气道血浆外渗。

Reduction by NG-nitro-L-arginine methyl ester (L-NAME) of antigen-induced nasal airway plasma extravasation in human subjects in vivo.

作者信息

Dear J W, Scadding G K, Foreman J C

机构信息

Department of Pharmacology, University College London.

出版信息

Br J Pharmacol. 1995 Sep;116(2):1720-2. doi: 10.1111/j.1476-5381.1995.tb16653.x.

DOI:10.1111/j.1476-5381.1995.tb16653.x
PMID:8528550
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1909081/
Abstract

In non-allergic subjects, histamine induced a reduction of minimal nasal cross-sectional area (Amin) and an increase in albumin release into nasal lavage. The effect of histamine on albumin release was inhibited by pretreatment with NG-nitro-L-arginine methyl ester (L-NAME), 1 mumol but not by D-NAME, 1 mumol. L-NAME, 1 and 10 mumol, did not inhibit the histamine-induced reduction of Amin. In subjects allergic to grass pollen, antigen challenge induced a reduction in Amin that was not changed by pretreatment with L-NAME, and an increase in albumin release that was inhibited by L-NAME, 1 mumol. The data support a role for nitric oxide in mediating plasma extravasation in the nose induced by antigen challenge or histamine.

摘要

在非过敏受试者中,组胺可导致最小鼻腔横截面积(Amin)减小,且鼻腔灌洗液中白蛋白释放增加。用1 μmol的NG-硝基-L-精氨酸甲酯(L-NAME)预处理可抑制组胺对白蛋白释放的作用,但1 μmol的D-NAME则无此作用。1 μmol和10 μmol的L-NAME均未抑制组胺诱导的Amin减小。在对草花粉过敏的受试者中,抗原激发可导致Amin减小,而L-NAME预处理对此无影响;同时抗原激发可使白蛋白释放增加,而1 μmol的L-NAME可抑制此作用。这些数据支持一氧化氮在介导抗原激发或组胺诱导的鼻腔血浆外渗中起作用。

相似文献

1
Reduction by NG-nitro-L-arginine methyl ester (L-NAME) of antigen-induced nasal airway plasma extravasation in human subjects in vivo.在体内通过 NG-硝基-L-精氨酸甲酯(L-NAME)减少人类受试者抗原诱导的鼻气道血浆外渗。
Br J Pharmacol. 1995 Sep;116(2):1720-2. doi: 10.1111/j.1476-5381.1995.tb16653.x.
2
Attenuation of human nasal airway responses to bradykinin and histamine by inhibitors of nitric oxide synthase.一氧化氮合酶抑制剂对人鼻气道对缓激肽和组胺反应的抑制作用
Br J Pharmacol. 1996 Jul;118(5):1177-82. doi: 10.1111/j.1476-5381.1996.tb15521.x.
3
Cutaneous permeability responses to bradykinin and histamine in the guinea-pig: possible differences in their mechanism of action.豚鼠皮肤对缓激肽和组胺的通透性反应:其作用机制的可能差异。
Br J Pharmacol. 1994 Jan;111(1):159-64. doi: 10.1111/j.1476-5381.1994.tb14038.x.
4
Nitric oxide attenuates platelet-activating factor induced nasal airway plasma extravasation in healthy subjects.
Eur J Clin Invest. 2002 Nov;32(11):858-61. doi: 10.1046/j.1365-2362.2002.01027.x.
5
The role of nitric oxide in the neural control of nasal fluid production.一氧化氮在鼻液分泌神经控制中的作用。
Am J Rhinol. 1997 Jul-Aug;11(4):303-11. doi: 10.2500/105065897781446667.
6
Nitric oxide is a mediator of neurogenic vascular exudation in the nose.一氧化氮是鼻部神经源性血管渗出的介质。
Otolaryngol Head Neck Surg. 1997 Mar;116(3):294-300. doi: 10.1016/S0194-59989770263-8.
7
Mechanism of bradykinin-induced plasma extravasation in the rat knee joint.缓激肽诱导大鼠膝关节血浆外渗的机制。
Br J Pharmacol. 1995 Jun;115(4):641-7. doi: 10.1111/j.1476-5381.1995.tb14980.x.
8
Nitric oxide is a mediator of the late-phase response in an animal model of nasal allergy.一氧化氮是鼻过敏动物模型中迟发相反应的介质。
Otolaryngol Head Neck Surg. 2000 May;122(5):706-11. doi: 10.1016/S0194-5998(00)70201-4.
9
Characterization of airway nitric oxide in allergic rhinitis: the effect of intranasal administration of L-NAME.变应性鼻炎气道一氧化氮的特征:鼻内给予L-精氨酸甲酯的影响
Allergy. 2003 Sep;58(9):885-92. doi: 10.1034/j.1398-9995.2003.00098.x.
10
NG-nitro-L-arginine methyl ester attenuates the maintenance and expression of methamphetamine-induced behavioral sensitization and enhancement of striatal dopamine release.NG-硝基-L-精氨酸甲酯可减弱甲基苯丙胺诱导的行为敏化的维持和表达以及纹状体多巴胺释放的增强。
J Pharmacol Exp Ther. 1996 Jun;277(3):1424-30.

引用本文的文献

1
Induction by inhibitors of nitric oxide synthase of hyperresponsiveness in the human nasal airway.一氧化氮合酶抑制剂诱导人鼻气道高反应性
Br J Pharmacol. 2000 Sep;131(2):363-9. doi: 10.1038/sj.bjp.0703561.

本文引用的文献

1
Mechanisms of histamine-induced coronary vasodilatation: H1-receptor-mediated release of endothelium-derived nitric oxide.组胺诱导冠状动脉扩张的机制:H1受体介导的内皮源性一氧化氮释放。
J Vasc Res. 1993 May-Jun;30(3):132-8. doi: 10.1159/000158987.
2
Acoustic rhinometry compared with posterior rhinomanometry in the measurement of histamine- and bradykinin-induced changes in nasal airway patency.在测量组胺和缓激肽引起的鼻气道通畅性变化方面,声反射鼻测量法与后鼻测压法的比较。
Br J Clin Pharmacol. 1994 Jan;37(1):33-7. doi: 10.1111/j.1365-2125.1994.tb04235.x.
3
Biology and clinical relevance of nitric oxide.一氧化氮的生物学特性及临床意义
BMJ. 1994 Aug 13;309(6952):453-7. doi: 10.1136/bmj.309.6952.453.
4
High nitric oxide production in human paranasal sinuses.人鼻窦中一氧化氮的高产量。
Nat Med. 1995 Apr;1(4):370-3. doi: 10.1038/nm0495-370.
5
Neuronal nitric oxide synthase is localized in extrinsic nerves regulating perireceptor processes in the chemosensory nasal mucosae of rats and humans.神经元型一氧化氮合酶定位于调节大鼠和人类化学感应性鼻黏膜中感受器周围过程的外周神经中。
J Comp Neurol. 1994 Jul 1;345(1):125-38. doi: 10.1002/cne.903450110.
6
Kinins are generated in vivo following nasal airway challenge of allergic individuals with allergen.在变应性个体的气道经变应原激发后,体内会生成激肽。
J Clin Invest. 1983 Nov;72(5):1678-85. doi: 10.1172/JCI111127.
7
Mediator release after nasal airway challenge with allergen.变应原进行鼻气道激发后介质的释放。
Am Rev Respir Dis. 1983 Oct;128(4):597-602. doi: 10.1164/arrd.1983.128.4.597.
8
Effect of terfenadine and placebo on symptoms after nasal allergen provocation.特非那定和安慰剂对鼻过敏原激发后症状的影响。
Clin Allergy. 1988 Jan;18(1):63-9. doi: 10.1111/j.1365-2222.1988.tb02844.x.
9
The nasal allergic reaction: observations on the role of histamine.鼻过敏反应:关于组胺作用的观察
Clin Exp Allergy. 1991 May;21 Suppl 2:13-9. doi: 10.1111/j.1365-2222.1991.tb01753.x.
10
Reduced allergen-induced nasal congestion and leukotriene synthesis with an orally active 5-lipoxygenase inhibitor.
N Engl J Med. 1990 Dec 20;323(25):1745-8. doi: 10.1056/NEJM199012203232506.